Skip to main content
PMC home page
Wiley - PMC COVID-19 Collection logoLink to Wiley - PMC COVID-19 Collection
. 2008 Jun 28;15(5):438–444. doi: 10.1111/j.1939-1676.2001.tb01572.x

A Review of Coronavirus Infection in the Central Nervous System of Cats and Mice

Janet E Foley 1,2,✉, Christian Leutenegger 2
PMCID: PMC7166525  PMID: 11596730

Abstract

Feline infectious peritonitis (FIP) is a common cause of death in cats. Management of this disease has been hampered by difficulties identifying the infection and determining the immunological status of affected cats and by high variability in the clinical, pathological, and immunological characteristics of affected cats. Neurological FIP, which is much more homogeneous than systemic effusive or noneffusive FIP, appears to be a good model for establishing the basic features of FIP immunopathogenesis. Very little information is available about the immunopathogenesis of neurologic FIP, and it is reasonable to use research from the well‐characterized mouse hepatitis virus (MHV) immune‐mediated encephalitis system, as a template for FIP investigation, and to contrast findings from the MHV model with those of FIP. It is expected that the immunopathogenic mechanisms will have important similarities. Such comparative research may lead to better understanding of FIP immunopathogenesis and rational prospects for management of this frustrating disease.

Keywords: Cats, Feline infectious peritonitis, Mouse hepatitis virus, Neurological disease

Based on a presentation to the ACVIM annual meeting, neurology section, May 2000.

References

  • 1. Foley J, Pedersen N. The inheritance of susceptibility to feline infectious peritonitis in purebred catteries. Feline Pract 1996;24:14–22. [Google Scholar]
  • 2. Poland AM, Vennema H, Foley JE, et al. Two related strains of feline infectious peritonitis virus isolated from immunocompromised cats infected with a feline enteric coronavirus. J Clin Microbiol 1996; 34:3180–3184. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Vennema H, Poland A, Hawkins KF, et al. A comparison of the genomes of FECVs and FIPVs and what they tell us about the relationships between feline coronaviruses and their evolution. Feline Pract 1995;23:40–46. [Google Scholar]
  • 4. Vennema H, Poland A, Foley J, et al. Feline infectious peritonitis viruses arise by mutation from endemic feline enteric coronaviruses. Virology 1998;243:150–157. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Herrewegh AA, Smeenk I, Horzinek MC, et al. Feline corona‐virus type II strains 79–1683 and 79–1146 originate from a double recombination between feline coronavirus type I and canine corona‐virus. J Virol 1998;72:4508–4514. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Herrewegh AA, Vennema H, Horzinek MC, et al. The molecular genetics of feline coronaviruses: Comparative sequence analysis of the ORF7a/7b transcription unit of different biotypes. Virology 1995;212: 622–631. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Vennema H, Heijnen L, Rottier PJ, et al. A novel glycoprotein of feline infectious peritonitis coronavirus contains a KDEL‐like en‐doplasmic reticulum retention signal. J Virol 1992;66:4951–4956. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Sturman LS, Ricard CS, Holmes KV. Proteolytic cleavage of the E2 glycoprotein of murine coronavirus: Activation of cell‐fusing activity of virions by trypsin and separation of two different 90K cleavage fragments. J Virol 1985;56:904–911. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Dalziel RG, Lampert PW, Talbot PJ, et al. Site‐specific alteration of murine hepatitis virus type 4 peplomer glycoprotein E2 results in reduced neurovirulence. J Virol 1986;59:463–471. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Jouvenne P, Mounir S, Stewart JN, et al. Sequence analysis of human coronavirus 229E mRNAs 4 and 5: Evidence for polymorphism and homology with myelin basic protein. Virus Res 1992;22:125–141. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Pedersen NC. An overview of feline enteric coronavirus and infectious peritonitis virus infections. Feline Pract 1995;23:7–22. [Google Scholar]
  • 12. Foley JE, Poland A, Carlson J, et al. Risk factors for feline infectious peritonitis among cats in multiple‐cat environments with endemic feline enteric coronavirus. J Am Vet Med Assoc 1997;210: 1313–1318. [PubMed] [Google Scholar]
  • 13. Fenner W. Inflammations of the nervous system In: August J, ed. Consultations in Feline Internal Medicine. Philadelphia , PA : WB Saunders; 1991: 507–517. [Google Scholar]
  • 14. Kornegay J. Feline infectious peritonitis: The central nervous system form. J Am Anim Hosp Assoc 1978; 14:580–584. [Google Scholar]
  • 15. Foley J, Lapointe J‐M, Koblik P, et al. Diagnostic features of neurologic feline infectious peritonitis. J Vet Intern Med 1998;12:36–63. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Kline K, Joseph R, Averill D. Feline infectious peritonitis with neurological involvement: Clinical and pathological findings in 24 cats. J Am Anim Hosp Assoc 1994;30:111–118. [Google Scholar]
  • 17. Pedersen N. Feline infectious peritonitis and feline enteric coronavirus infections. Part 2: Feline infectious peritonitis. Feline Pract 1983;13:5–19. [Google Scholar]
  • 18. Greene CE, McDermott M, Jameson PH, et al. Bartonella hen‐selae infection in cats: Evaluation during primary infection, treatment, and rechallenge infection. J Clin Microbiol 1996;34:1682–1685. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. August J. Feline infectious peritonitis: An immune‐mediated coronaviral vasculitis. Vet Clin North Am Small Anim Pract 1984; 14: 971–984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Fazakerley JK, Parker SE, Bloom F, et al. The V5A13.1 envelope glycoprotein deletion mutant of mouse hepatitis virus type‐4 is neuroattenuated by its reduced rate of spread in the central nervous system. Virology 1992;187:178–188. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. Perlman S, Schelper R, Bolger E, et al. Late onset, symptomatic, demyelinating encephalomyelitis in mice infected with MHV‐JHM in the presence of maternal antibody. Microb Pathogenesis 1987; 2:185–194. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Houtman J, Fleming J. Dissociation of demyelination and viral clearance in congenitally immunodeficient mice infected with murine coronavirus JHM. Neurovirology 1996;2:101–110. [DOI] [PubMed] [Google Scholar]
  • 23. Buchmeier MJ, Dalziel RG, Koolen MJ, et al. Molecular determinants of CNS virulence of MHV‐4. Adv Exp Med Biol 1987;218: 287–295. [DOI] [PubMed] [Google Scholar]
  • 24. Fleming JO, Trousdale MD, Bradbury J, et al. Experimental demyelination induced by coronavirus JHM (MHV‐4): Molecular identification of a viral determinant of paralytic disease. Microb Pathogenesis 1987;3:9–20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. Pearce BD, Hobbs MV, McGraw TS, et al. Cytokine induction during T‐cell‐mediated clearance of mouse hepatitis virus from neurons in vivo. J Virol 1994;68:5483–5495. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. Kipar A, Bellmann S, Kremendahl J, et al. Cellular composition, coronavirus antigen expression and production of specific antibodies in lesions in feline infectious peritonitis. Vet Immunol Immu-nopathol 1998;65:243–257. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. Slauson D, Finn J. Meningoencephalitis and panophthalmitis in feline infectious peritonitis. J Am Vet Med Assoc 1972;160:729–734. [PubMed] [Google Scholar]
  • 28. Krum S, Johnson K, Wilson J. Hydrocephalus associated with the noneffusive form of feline infectious peritonitis. J Am Vet Med Assoc 1975;167:746–748. [PubMed] [Google Scholar]
  • 29. Legendre A, Whitenack D. Feline infectious peritonitis with spinal cord involvement in two cats. J Am Vet Med Assoc 1975;160: 729–734. [PubMed] [Google Scholar]
  • 30. Summers B, Cummings J, de Lahunta A. Feline infectious peritonitis In: Veterinary Neuropathology. St. Louis , MO : Mosby Year‐Book; 1995: 119–121. [Google Scholar]
  • 31. Tamke P, Petersen M, Dietze A, et al. Acquired hydrocephalus and hydromyelia in a cat with feline infectious peritonitis: A case report and brief review. J Can Vet 1988;29:997–1000. [PMC free article] [PubMed] [Google Scholar]
  • 32. Lampert PW, Sims JK, Kniazeff AJ. Mechanism of demyelination in JHM virus encephalomyelitis. Electron microscopic studies. Acta Neuropathol 1973;24:76–85. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33. Lavi E, Wang Q. The protective role of cytotoxic T cells and interferon against coronavirus invasion of the brain In: Talbot P, Levy G, eds. Corona‐ and Related Viruses. New York , NY : Plenum Press; 1995: 145–149. [DOI] [PubMed] [Google Scholar]
  • 34. Cabirac G, Murray R, McLaughlin L, et al. In vitro interaction of coronaviruses with primate and human brain microvascular endo‐thelial cells In: Talbot P, Levy G, eds. Corona‐ and Related Viruses. New York , NY : Plenum Press; 1995: 79–88. [DOI] [PubMed] [Google Scholar]
  • 35. Weiner LP Pathogenesis of demyelination induced by a mouse hepatitis. Arch Neurol 1973;28:298–303. [DOI] [PubMed] [Google Scholar]
  • 36. Tammer R, Eversen O, Lutz H, et al. Immunohistological demonstration of feline infectious peritonitis virus antigen in paraffin‐embedded tissues using feline ascites or murine monoclonal antibodies. Vet Immunol Immunopathol 1995;49:177–182. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37. Paltrinieri S, Cammarata MP, Cammarata G, et al. Some aspects of humoral and cellular immunity in naturally occurring feline infectious peritonitis. Vet Immunol Immunopathol 1998;65:205–220. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38. Barnett EM, Perlman S. The olfactory nerve and not the trigeminal nerve is the major site of CNS entry for mouse hepatitis virus, strain JHM. Virology 1993; 194:185–191. [DOI] [PubMed] [Google Scholar]
  • 39. Barthold SW, Smith AL. Viremic dissemination of mouse hepatitis virus‐JHM following intranasal inoculation of mice. Arch Virol 1992;122:35–44. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40. Cabirac GF, Soike KF, Zhang JY, et al. Entry of coronavirus into primate CNS following peripheral infection. Microb Pathogenesis 1994;16:349–357. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41. Lachance C, Arbour N, Cashman NR, et al. Involvement of aminopeptidase N (CD13) in infection of human neural cells by human coronavirus 229E. J Virol 1998;72:6511–6519. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42. Patterson S, Macnaughton MR. Replication of human respiratory coronavirus strain 229E in human macrophages. J Gen Virol 1982;60:307–314. [DOI] [PubMed] [Google Scholar]
  • 43. Taguchi F, Siddell SG, Wege H, et al. Characterization of a variant virus selected in rat brains after infection by coronavirus mouse hepatitis virus JHM. J Virol 1985;54:429–435. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44. Sun N, Perlman S. Spread of a neurotropic coronavirus to spinal cord white matter via neurons and astrocytes. J Virol 1995;69:633–641. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45. Cserr HF, DePasquale M, Harling‐Berg CJ, et al. Afferent and efferent arms of the humoral immune response to CSF‐administered albumins in a rat model with normal blood‐brain barrier permeability. J Neuroimmunol 1992;41:195–202. [DOI] [PubMed] [Google Scholar]
  • 46. Hickey WF, Hsu BL, Kimura H. T‐lymphocyte entry into the central nervous system. J Neurosci Res 1991;28:254–260. [DOI] [PubMed] [Google Scholar]
  • 47. Weiss R, Scott E. Pathogenesis of feline infectious peritonitis: Pathologic changes and immunofluorescence. Am J Vet Res 1981;42: 2036–2048. [PubMed] [Google Scholar]
  • 48. Pedersen N, Boyle J. Immunologic phenomena in the effusive form of feline infectious peritonitis. Am J Vet Res 1980;41:868–876. [PubMed] [Google Scholar]
  • 49. Jacobse‐Geels HE, Daha MR, Horzinek MC. Isolation and characterization of feline C3 and evidence for the immune complex pathogenesis of feline infectious peritonitis. J Immunol 1980;125:1606–1610. [PubMed] [Google Scholar]
  • 50. Weiss R, Scott E. Pathogenesis of feline infectious peritonitis: Nature and development of viremia. Am J Vet Res 1981;42:382–390. [PubMed] [Google Scholar]
  • 51. Vennema H, de Groot RJ, Harbour DA, et al. Early death after feline infectious peritonitis virus challenge due to recombinant vaccinia virus immunization. J Virol 1990;64:1407–1409. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52. Hohdatsu T, Nakamura M, Ishizuka Y, et al. A study on the mechanism of antibody‐dependent enhancement of feline infectious peritonitis virus infection in feline macrophages by monoclonal antibodies. Arch Virol 1991;120:207–217. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53. Olsen CW, Corapi WV, Ngichabe CK, et al. Monoclonal antibodies to the spike protein of feline infectious peritonitis virus mediate antibody‐dependent enhancement of infection of feline macrophages. J Virol 1992;66:956–965. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54. Corapi WV, Olsen CW, Scott FW. Monoclonal antibody analysis of neutralization and antibody‐dependent enhancement of feline infectious peritonitis virus. J Virol 1992;66:6695–6705. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55. Haagmans BL, Egberink HF, Horzinek MC. Apoptosis and T‐cell depletion during feline infectious peritonitis. J Virol 1996;70: 8977–8983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56. Dean G, Woo J, Lavoy A, et al. Cytokine expression in feline lymphoid tissue in health and disease. Feline immunology workshop, University of California, Davis, CA, 1997.
  • 57. Goitsuka R, Ohashi T, Ono K, et al. IL‐6 activity in feline infectious peritonitis. J Immunol 1990; 144:2599–2603. [PubMed] [Google Scholar]
  • 58. Gunn‐Moore DA, Caney SM, Gruffydd‐Jones TJ, et al. Antibody and cytokine responses in kittens during the development of feline infectious peritonitis (FIP). Vet Immunol Immunopathol 1998; 65:221–242. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59. Hasegawa T, Hasegawa A. Interleukin 1 alpha mRNA‐express‐ing cells on the local inflammatory response in feline infectious peritonitis. J Vet Med Sci 1991;53:995–999. [DOI] [PubMed] [Google Scholar]
  • 60. Deli MA, Descamps L, Dehouck MP, et al. Exposure of tumor necrosis factor‐alpha to luminal membrane of bovine brain capillary endothelial cells cocultured with astrocytes induces a delayed increase of permeability and cytoplasmic stress fiber formation of actin. J Neu-rosci Res 1995;41:717–726. [DOI] [PubMed] [Google Scholar]
  • 61. Duchini A, Govindarajan S, Santucci M, et al. Effects of tumor necrosis factor‐alpha and interleukin‐6 on fluid‐phase permeability and ammonia diffusion in CNS‐derived endothelial cells. J Invest Med 1996;44:474–482. [PubMed] [Google Scholar]
  • 62. Stohlman SA, Matsushima GK, Casteel N, et al. In vivo effects of coronavirus‐specific T cell clones: DTH inducer cells prevent a lethal infection but do not inhibit virus replication. J Immunol 1986; 136:3052–3056. [PubMed] [Google Scholar]
  • 63. Fleming JO, Shubin RA, Sussman MA, et al. Monoclonal antibodies to the matrix (El) glycoprotein of mouse hepatitis virus protect mice from encephalitis. Virology 1989;168:162–167. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64. Wang FI, Stohlman SA, Fleming JO. Demyelination induced by murine hepatitis virus JHM strain (MHV‐4) is immunologically mediated. J Neuroimmunol 1990;30:31–41. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65. Dörries R, Schwender S, Imrich H, et al. Population dynamics of lymphocyte subsets in the central nervous system of rats with different susceptibility to coronavirus‐induced demyelinating encephalitis. Immunology 1991;74:539–545. [PMC free article] [PubMed] [Google Scholar]
  • 66. Stohlman SA, Bergmann CC, van der Veen RC, et al. Mouse hepatitis virus‐specific cytotoxic T lymphocytes protect from lethal infection without eliminating virus from the central nervous system. J Virol 1995;69:684–694. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67. Castro RF, Evans GD, Jaszewski A, et al. Coronavirus‐induced demyelination occurs in the presence of virus‐specific cytotoxic T cells. Virology 1994;200:733–743. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68. Pewe L, Xue S, Perlman S. Infection with cytotoxic T‐lympho‐cyte escape mutants results in increased mortality and growth retardation in mice infected with a neurotropic coronavirus. J Virol 1998; 72:5912–5918. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69. Shibata S, Kyuwa S, Lee SK, et al. Apoptosis induced in mouse hepatitis virus‐infected cells by a virus‐specific CD8+ cytotoxic T‐lymphocyte clone. J Virol 1994;68:7540–7545. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70. Schmied M, Breitschopf H, Gold R, et al. Apoptosis of T lymphocytes in experimental autoimmune encephalomyelitis. Evidence for programmed cell death as a mechanism to control inflammation in the brain. Am J Pathol 1993;143:446–452. [PMC free article] [PubMed] [Google Scholar]
  • 71. Körner H, Schliephake A, Winter J, et al. Nucleocapsid or spike protein‐specific CD4+ T lymphocytes protect against coronavirus‐induced encephalomyelitis in the absence of CD8+ T cells. J Immunol 1991;147:2317–2323. [PubMed] [Google Scholar]
  • 72. Sussman MA, Shubin RA, Kyuwa S, et al. T‐cell‐mediated clearance of mouse hepatitis virus strain JHM from the central nervous system. J Virol 1989;63:3051–3056. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73. Williamson JS, Stohlman SA. Effective clearance of mouse hepatitis virus from the central nervous system requires both CD4+ and CD8+ T cells. J Virol 1990;64:4589–4592. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74. Schwender S, Hein A, Imrich H, et al. On the role of different lymphocyte subpopulations in the course of coronavirus MHV IV (JHM)‐induced encephalitis in Lewis rats. Adv Exp Med Biol 1993; 342:425–430. [DOI] [PubMed] [Google Scholar]
  • 75. Lane TE, Liu MT, Chen BP, et al. A central role for CD4(+) T cells and RANTES in virus‐induced central nervous system inflammation and demyelination. J Virol 2000;74:1415–1424. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76. Perlman S, Sun N, Barnett E. Spread of MHV‐JHM from nasal cavity to white matter of spinal cord In: Talbot P, Levy G, eds. Corona‐and Related Viruses. New York , NY : Plenum Press; 1995: 73–78. [DOI] [PubMed] [Google Scholar]
  • 77. Sun N, Grzybicki D, Castro RF, et al. Activation of astrocytes in the spinal cord of mice chronically infected with a neurotropic coronavirus. Virology 1995;213:482–493. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78. Tracey KJ, Cerami A. Tumor necrosis factor, other cytokines and disease. Annu Rev Cell Biol 1993;9:317–343. [DOI] [PubMed] [Google Scholar]
  • 79. Lotz M. Interleukin‐6: A comprehensive review. Cancer Treatment Res 1995;80:209–233. [DOI] [PubMed] [Google Scholar]
  • 80. Samoilova EB, Horton JL, Hilliard B, et al. IL‐6‐deficient mice are resistant to experimental autoimmune encephalomyelitis: Roles of IL‐6 in the activation and differentiation of autoreactive T cells. J Immunol 1998;161:6480–6486. [PubMed] [Google Scholar]
  • 81. Akira S, Taga T, Kishimoto T. Interleukin‐6 in biology and medicine. Adv Immunol 1993;54:1–78. [DOI] [PubMed] [Google Scholar]
  • 82. Tilg H, Dinarello CA, Mier JW. IL‐6 and APPs: Anti‐inflammatory and immunosuppressive mediators. Immunol Today 1997;18: 428–432. [DOI] [PubMed] [Google Scholar]
  • 83. Parra B, Hinton DR, Lin MT, et al. Kinetics of cytokine mRNA expression in the central nervous system following lethal and nonlethal coronavirus‐induced acute encephalomyelitis. Virology 1997;233:260–270. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 84. Lin MT, Hinton DR, Parra B, et al. The role of IL‐10 in mouse hepatitis virus‐induced demyelinating encephalomyelitis. Virology 1998;245:270–280. [DOI] [PubMed] [Google Scholar]
  • 85. Parra B, Hinton DR, Marten NW, et al. IFN‐gamma is required for viral clearance from central nervous system oligodendroglia. J Immunol 1999; 162:1641–1647. [PubMed] [Google Scholar]
  • 86. Smith AL, Barthold SW, de Souza MS, et al. The role of gamma interferon in infection of susceptible mice with murine coronavirus, MHV‐JHM. Arch Virol 1991;121:89–100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 87. Collins AR. Interferon gamma potentiates human coronavirus OC43 infection of neuronal cells by modulation of HLA class I expression. Immunol Invest 1995;24:977–986. [DOI] [PubMed] [Google Scholar]
  • 88. Lane TE, Asensio VC, Yu N, et al. Dynamic regulation of alpha‐ and beta‐chemokine expression in the central nervous system during mouse hepatitis virus‐induced demyelinating disease. J Immunol 1998;160:970–978. [PubMed] [Google Scholar]
  • 89. Sasseville VG, Smith MM, Mackay CR, et al. Chemokine expression in simian immunodeficiency virus‐induced AIDS encephalitis. Am J Pathol 1996;149:1459–1467. [PMC free article] [PubMed] [Google Scholar]
  • 90. Asensio VC, Campbell IL. Chemokine gene expression in the brains of mice with lymphocytic choriomeningitis. J Virol 1997;71: 7832–7840. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 91. Postorino Reeves N. Vaccination against naturally occurring FIP in a single large cat shelter. Feline Pract 1995;23:82–91. [Google Scholar]
  • 92. Gerber J. Overview of the development of a modified live temperature‐sensitive FIP virus vaccine. Feline Pract 1995;23:62–66. [Google Scholar]
  • 93. McArdle F, Tennant B, Bennett M, et al. Independent evaluation of a modified live feline infectious peritonitis virus vaccine under experimental conditions (University of Liverpool experience). Feline Pract 1995;23:67–71. [Google Scholar]
  • 94. Scott F, Corapi W, Olsen C. Independent evaluation of a modified live FIPV vaccine under experimental conditions (Cornell experience). Feline Pract 1995;23:74–76. [Google Scholar]
  • 95. Daniel C, Talbot PJ. Protection from lethal coronavirus infection by affinity‐purified spike glycoprotein of murine hepatitis virus, strain A59. Virology 1990;174:87–94. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 96. Talbot PJ, Dionne G, Lacroix M. Vaccination against lethal coronavirus‐induced encephalitis with a synthetic decapeptide homologous to a domain in the predicted peplomer stalk. J Virol 1988;62: 3032–3036. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 97. Koolen MJ, Borst MA, Horzinek MC, et al. Immunogenic pep‐tide comprising a mouse hepatitis virus A59 B‐cell epitope and an influenza virus T‐cell epitope protects against lethal infection. J Virol 1990;64:6270–6273. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 98. Koo M, Bendahmane M, Lettieri GA, et al. Protective immunity against murine hepatitis virus (MHV) induced by intranasal or subcutaneous administration of hybrids of tobacco mosaic virus that carries an MHV epitope. Proceedings of the National Academy of Sciences of the United States of America 1999;96:7774–7779. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 99. Townsend GC, Scheld WM. Adjunctive therapy for bacterial meningitis: Rationale for use, current status, and prospects for the future. Clin Infect Dis 1993;17(Suppl 2):S537–S549. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Veterinary Internal Medicine are provided here courtesy of Wiley

RESOURCES